Comments for GSK - Stockpickr! Your Source for Stock Ideas

Comments for GSK

Added By	Comments	Type	Date Added
Dan2009	Good drug pipes and management	Love	July 08, 2009
barrons3	GSK (GSK) also got a lot of juice on Tuesday on a tough tape, adds Tim Seymour. It may be worth a look.	Love	June 17, 2009
barrons3	Huckman mentioned two companies that make anti-virals: GlaxoSmithKline(GKS), which makes Relenza, and Gilead Sciences (GILD), which gets a 20% royalty for Tamiflu, a drug it makes for Roche.	Love	April 29, 2009
Stockpickr Staff	Adam Feuerstein: "GlaxoSmithKline (GSK) sells the other flu antiviral medicine, Relenza." <a href="http://www.thestreet.com/story/10492439/1/top-takes-from-realmoney.html" target="_blank">Read more here.</a>	Love	April 27, 2009
barrons3	Najarian also liked GlaxoSmithKline(GSK) for going out and buying closely held Stiefel Laboratories for $3.4 billion, including debt.	Love	April 22, 2009
Stockpickr Staff	Adam Feuerstein: "Today's announcement that GlaxoSmithKline (GSK) and Pfizer (PFE) are merging their respective HIV drug businesses is a sign that Glaxo (and perhaps Pfizer as well) is no longer able to compete in the market against Gilead Sciences (GILD)." <a href="http://www.thestreet.com/story/10487177/1/top-takes-from-realmoney.html" target="_blank">Read more on <I>TheStreet.com</I>.</a>	Love	April 16, 2009
rdjmurrieta	My big-cap Pharma Play. Oh-well.	Love	March 27, 2009
sarah z	From a recent Mad Money show:"I'm positive on GSK, although I haven't heard a lot from Obama to really jump start this sector yet."	Love	January 01, 2009
sarah z	From a recent Mad Money show:"I'm positive on GSK, although I haven't heard a lot from Obama to really jump start this sector yet."	Love	December 30, 2008
biancofj	sound	Love	November 25, 2008
barrons3	With pharma shares down only 11% in a year that has seen many stocks crater by 30% or 40% or 50%, the industry's charms aren't exactly undiscovered. Still, Roche Holdings (RHHBY) and Novartis (NVS) remain in the Morgan Stanley European model portfolio, and could continue to outperform, Draaisma says. GlaxoSmithKline (GSK) derives about 45% of sales from the U.S., and also could be helped by a higher buck. Historically, price increases in all three drug stocks have been among the most highly correlated with a rising dollar.	Love	November 08, 2008
barrons3	Drug companies could take some big hits as Democrats struggle to hammer out a workable universal-health-care scheme. Obama and Democrats in Congress are intent on bringing down the costs of drugs and services. Drug makers fear losses in revenue as Democrats push to negotiate lower drug prices under Medicare. Shares of Pfizer (PFE) and GlaxoSmithKline (GSK) both fell 8% the day after the election. Each stock is trading roughly 30% below its 52-week high.	Love	November 08, 2008
stockerblog	5.5%	Love	October 20, 2008
ron2075sc	strong co.	Love	October 14, 2008
barrons3	Stubbs likes telecom, pharmaceutical and insurance sectors in general. For those who haven't completely soured on equity, the strategist has screened for stocks that offer a dividend yield above 4%; strong cash flow; decent dividend cover; a good balance sheet and a positive earnings picture. Among the names on this list: ENI (ticker: E); Vodafone Group (VOD), France Telecom (FTE); GlaxoSmithKline (GSK) and AstraZeneca (AZN).	Love	October 11, 2008
kl1070	risky	Hate	August 06, 2008
gadams11	Following pro portfolio	Love	May 02, 2008
stockerblog	Wellbutrin, Paxil	Love	April 21, 2008
Bdogz	been good to me	Love	April 13, 2008
stockerblog	Advair, also known as Seretide which expires in 2010	Love	April 06, 2008
stockerblog	The stock has a P/E of 11 , a PEG of 4.19	Love	March 31, 2008
jmgulnac	Warren Buffet	Love	March 23, 2008
barrons2	I also think that we are at levels where you can get a bounce on the plus-5% yields of GlaxoSmithKline (GSK) and Bristol Myers (BMY).	Love	March 12, 2008
TA79Bandit	Pharma	Love	March 03, 2008
El0dia	Buffitt Play	Love	February 22, 2008
barrons2	Buy - Price 41.93 on Feb. 13 by UBS Target: 52.55. Despite beating both on the top-line and bottom-line on 4Q numbers, GSK saw a sharp sell-off (stock down ~8%) following disappointing FY08 EPS guidance...From sum of parts, we see 30% implied discounts for GSK's pharma division relative to EU large-cap pharma...We believe valuation implies GSK's pipeline is cheap-to-free. With key catalysts on darapladib (atherosclerosis), Promacta (thrombocytopenia), and possibly son of Advair (asthma/COPD) in the year ahead, we expect excess performance. GSK's 10% [free-cash-flow] yield, 5% dividend yield, and ability to repurchase up to 10% of shares in '08 ensures some benefit to investors. Upgraded to Buy. Market-cap: $117 billion.	Love	February 16, 2008
buffett	healthcare	Love	February 10, 2008
voltnfan	Bargain at $42 level with 6% dividend	Love	February 09, 2008
stockerblog	P/E is 14 and the yield of 4%.	Love	December 17, 2007
shadow9509	2nd largest drug company in world and is going to heavy ad vertise alli.their diet pill only drug approved by fda over the counter	Love	November 05, 2007